NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
Clinical Trials
27 trialsNCT02037048 2024-01-08
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
Case Comprehensive Cancer Center
Phase 2 Unknown
NCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
NCT03094884 2023-05-23
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
Fox Chase Cancer Center
Phase 1 Unknown
NCT02288195 2023-05-12
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Sun Yat-sen University
Phase 3 Unknown
NCT02773485 2022-10-21
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
Phase 3 Unknown
NCT05399394 2022-06-01
FOLRT
Campus Bio-Medico University
Phase 2 Unknown
NCT05374252 2022-05-16
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT01889303 2022-02-14
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer
Wuhan University
Phase 2 Unknown
NCT05174117 2021-12-30
Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology
Phase NA Unknown
NCT05007145 2021-12-21
REVO
Fujian Cancer Hospital
Phase 2 Unknown
NCT04426955 2021-09-16
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT05002686 2021-08-24
Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis
Ruijin Hospital
Phase 2/3 Unknown
NCT03374293 2021-02-10
Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT03940001 2019-09-09
A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer
Zhejiang Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT02812641 2019-03-11
Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC
National Taiwan University Hospital
Phase 2 Unknown
NCT03702985 2019-01-23
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
Fudan University
Phase 2 Unknown
NCT03213054 2018-09-26
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer
Oncolys BioPharma Inc
Phase 1 Unknown
NCT03273647 2017-10-19
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
Fudan University
Phase 3 Unknown
NCT02384811 2017-09-07
Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
Fudan University
Phase 2 Unknown
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT02461043 2015-09-01
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 3 Unknown
NCT01818973 2015-06-08
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT01937208 2013-09-09
Comparable Study of Different Radiation Dose in Esophageal Carcinoma
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT01227239 2012-11-27
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
Japan Clinical Cancer Research Organization
Phase 1/2 Unknown
NCT00842686 2012-03-26
CRAB
Institute of Oncology Ljubljana
Phase 2 Unknown
NCT00139633 2005-08-31
Selective Dose Escalation for Esophageal Cancer
The Oregon Clinic
Phase 2 Unknown